Findings seen for orthopedic surgery patients provided an opioid disposal kit at discharge
FRIDAY, Jan. 10, 2025 (HealthDay News) — Providing surgery patients with an opioid disposal kit at the time of discharge increases their self-disposal rates, according to a short report published online Jan. 1 in BMJ Open Quality.
Eric Shan, from the University of Pennsylvania in Philadelphia, and colleagues assessed the impact of opioid disposal kits on disposal rates after orthopedic surgery. The analysis included 1,321 eligible patients; comparisons were made for patients undergoing hip or knee arthroplasty from May to July 2022 versus July to September 2022 (when opioid disposal kits were provided at discharge).
The researchers found that disposal kits were associated with a 10.6 percentage point increase in disposal rates (20.8 to 28.4 percent) and a 10.5 percentage point increase in the fraction of opioids disposed (16.1 to 20.2 percent). The disposal kits were also found to be cost-effective, as each kit was valued at under $2.00.
“Any time we can cut down the number of opioids that could potentially circulate or be misused, it”s a positive step,” co-corresponding author Anish Agarwal, M.D., M.P.H., of the Center for Insights to Outcomes at the University of Pennsylvania Perelman School of Medicine, said in a statement. “If you can make the right decision the easy one, you”re much more likely to get a positive outcome, and I think that”s what we saw here.”
Withdrawal From Medetomidine Increasingly Seen in ICUs
Considerable Gaps Reported in Care for Youth With Opioid Use Disorder
Study Looks at Patient Experiences With Sedative Contaminating Fentanyl
Distinct Characteristics ID"d for Patients With Rheumatoid Conditions, Opioid Use Disorder
Holding DMARDs at Time of COVID-19 Vaccine Not Warranted in Those With Inflammatory Arthritis
1 in 3 With Lupus Take Supplements, Medications With Potential for Interactions
Low Hydroxychloroquine Intake, Blood Levels Linked to ASCVD Risk in Lupus
Rheumatic Immune-Related AEs With Immune Checkpoint Inhibitors More Severe Than Previously Reported